G. Steven Burrill has landed in a fresh tub of hot water over allegations he embezzled millions of dollars from a biotech fund he ran-a year after one of his former staffers filed suit claiming that more than $20 million was diverted, which in turn prompted the fund's institutional investors to boot the venture exec [...]
